Compare Orchid Chemicals with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs AJANTA PHARMA - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD AJANTA PHARMA ORCHID PHARMA LTD/
AJANTA PHARMA
 
P/E (TTM) x -0.5 22.5 - View Chart
P/BV x 0.1 4.0 3.0% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ORCHID PHARMA LTD   AJANTA PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
AJANTA PHARMA
Mar-19
ORCHID PHARMA LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1941,422 13.6%   
Low Rs35898 3.9%   
Sales per share (Unadj.) Rs276.5233.5 118.4%  
Earnings per share (Unadj.) Rs-79.244.0 -180.2%  
Cash flow per share (Unadj.) Rs-43.552.2 -83.3%  
Dividends per share (Unadj.) Rs09.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs53.9255.1 21.1%  
Shares outstanding (eoy) m70.4588.02 80.0%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x0.45.0 8.3%   
Avg P/E ratio x-1.426.4 -5.5%  
P/CF ratio (eoy) x-2.622.2 -11.9%  
Price / Book Value ratio x2.14.5 46.7%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m8,067102,081 7.9%   
No. of employees `0002.86.8 41.2%   
Total wages/salary Rs m2,5274,307 58.7%   
Avg. sales/employee Rs Th6,956.13,022.6 230.1%   
Avg. wages/employee Rs Th902.5633.4 142.5%   
Avg. net profit/employee Rs Th-1,993.0569.1 -350.2%   
INCOME DATA
Net Sales Rs m19,47720,554 94.8%  
Other income Rs m407211 193.2%   
Total revenues Rs m19,88420,765 95.8%   
Gross profit Rs m1,1035,664 19.5%  
Depreciation Rs m2,519721 349.5%   
Interest Rs m5,22712 45,058.6%   
Profit before tax Rs m-6,2365,143 -121.3%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1251,273 -9.8%   
Profit after tax Rs m-5,5803,870 -144.2%  
Gross profit margin %5.727.6 20.5%  
Effective tax rate %2.024.8 8.1%   
Net profit margin %-28.718.8 -152.2%  
BALANCE SHEET DATA
Current assets Rs m11,01411,812 93.2%   
Current liabilities Rs m32,0603,776 849.0%   
Net working cap to sales %-108.139.1 -276.4%  
Current ratio x0.33.1 11.0%  
Inventory Days Days9577 122.6%  
Debtors Days Days3482 41.1%  
Net fixed assets Rs m29,44014,398 204.5%   
Share capital Rs m705175 401.7%   
"Free" reserves Rs m2,04322,277 9.2%   
Net worth Rs m3,80022,452 16.9%   
Long term debt Rs m9,0187 136,634.8%   
Total assets Rs m46,51026,962 172.5%  
Interest coverage x-0.2444.3 -0.0%   
Debt to equity ratio x2.40 807,321.1%  
Sales to assets ratio x0.40.8 54.9%   
Return on assets %-0.814.4 -5.3%  
Return on equity %-146.917.2 -852.0%  
Return on capital %-3.723.0 -16.3%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,51310,682 70.3%   
Fx outflow Rs m5,6492,102 268.7%   
Net fx Rs m1,8658,580 21.7%   
CASH FLOW
From Operations Rs m1,6823,748 44.9%  
From Investments Rs m-9,860-2,228 442.6%  
From Financial Activity Rs m6,644-1,475 -450.5%  
Net Cashflow Rs m-1,53545 -3,396.0%  

Share Holding

Indian Promoters % 32.3 73.8 43.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 1.6 296.8%  
FIIs % 3.3 7.6 43.4%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 17.0 325.3%  
Shareholders   84,811 20,968 404.5%  
Pledged promoter(s) holding % 54.9 4.4 1,251.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   UNICHEM LAB  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  ALEMBIC LTD  WYETH LTD  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Realty and Telecom Stocks Drag(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is flat while the Hang Seng is down 0.9%.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - DR. REDDYS LAB COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS